Alk Abello A/S (ALKb.CO) Key Developments | Reuters.com
Edition:
United States

Alk Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,120.00DKK
24 Jun 2016
Change (% chg)

kr.-28.00 (-2.44%)
Prev Close
kr.1,148.00
Open
kr.1,050.00
Day's High
kr.1,140.00
Day's Low
kr.1,050.00
Volume
14,687
Avg. Vol
19,529
52-wk High
kr.1,300.00
52-wk Low
kr.689.00

Latest Key Developments (Source: Significant Developments)

Alk Abello: Member of Management Board sells shares worth DKK 2.7 million
Friday, 20 May 2016 09:48am EDT 

Alk Abello A/S :Flemming Pedersen, Member of Board of Management, sold on May 20 a total of 2,191 Alk Abello shares at market value 2.7 million Danish crowns ($407,689).  Full Article

ALK-Abello names Carsten Hellmann new CEO
Wednesday, 18 May 2016 12:59am EDT 

ALK-Abello A/S : Said on Tuesday Board of Directors had appointed Carsten Hellmann as new President and Chief Executive . Hellmann is currently CEO of Merial and Executive Vice President and member of the Executive Committee of Sanofi .Hellmann to take up CEO position no later than Jan. 1, 2017.  Full Article

Alk Abello raises FY 2016 outlook
Wednesday, 4 May 2016 01:45am EDT 

Alk Abello A/S:Says updates FY 2016 guidance to reflect better than expected performance in Q1 and slightly clearer view of unfolding market situation in Europe.Says FY 2016 EBITDA is now expected to increase to around 575 million crowns (previously: about 450 million crowns) before special items, additional sales royalties and milestone payments.Says FY 2016 base business revenue now seen to grow organically by about 15 percent in local currencies to around 2.75 billion crowns (previous expectation: 10 percent growth and revenue of about 2.6 billion crowns).  Full Article

Alk Abello CEO Jens Bager steps down
Monday, 22 Feb 2016 11:07am EST 

Alk Abello A/S:Alk's CEO Jens Bager steps down.‍Search for a new CEO will be initiated immediately​.  Full Article

Alk Abello A/S gives FY 2016 guidance, proposes FY 2015 dividend
Tuesday, 9 Feb 2016 02:30am EST 

Alk Abello A/S:Partnerships are expected to further contribute to revenue and earnings, potential milestone payments in FY 2016-17 total 75 million​ Danish crowns ‍.Sees FY 2016 base business revenue to grow organically by about 10 pct to 2.6 billion​ crowns.Sees FY 2016 ‍EBITDA ex. items, ex. revenues from sales royalties and milestone payments, to increase by about 35 pct to 450 million crowns.Proposes dividend of ‍5 crowns per share​ for FY 2015​.  Full Article

Alk Abello A/S expands partnership into South-East Asian growth markets
Thursday, 28 Jan 2016 02:30am EST 

Alk Abello A/S:Expands partnership into South-East Asian growth markets​.Abbott will register and sell house dust mite (HDM) sublingual allergy immunotherapy (SLIT) tablet in 7 new growth markets in SE Asia​.Agreement is expected to have a positive, long-term effect on Alk's financial results.Deal not expected to have a material impact on 2016 financial results​.  Full Article

Alk Abello A/S: Marketing authorisation for Acarizax issued in France
Wednesday, 27 Jan 2016 04:00am EST 

Alk Abello A/S:Authorities in France have issued a marketing authorisation for ALK's new house dust mite sublingual allergy immuno-therapy tablet (slit-tablet), Acarizax​.  Full Article

Alk Abello announces results from GRAZAX Asthma Prevention trial in children
Thursday, 14 Jan 2016 11:05am EST 

Alk Abello A/S:Announces top-line results from the five-year landmark GRAZAX Asthma Prevention (GAP) trial in children.Says trial did not show an effect in terms of time to first diagnosis of reversible impairment of lung function.Trial demonstrated that GRAZAX treatment significantly reduced the proportion of children experiencing asthma symptoms or using asthma medication.Says this effect sustained two years after end of treatment.Trial confirmed that GRAZAX treatment significantly reduced allergic rhinoconjunctivitis symptoms.Says this effect sustained two years after end of treatment.  Full Article

Alk Abello raises FY 2015 forecasts after high French sales
Wednesday, 6 Jan 2016 11:24am EST 

Alk Abello A/S:Increases FY 2015 forecasts due to higher sales in France.FY 2015 revenue in the base business is now expected to grow by about 5 pct in local currencies (previously: 3 pct).FY 2015 EBITDA before special items is now expected to be about 450 million crowns (previously: about 400 million crowns).Year revenue is consequently now estimated at about 2.57 billion crowns (previously: around 2.5 billion crowns).Says the updated guidance reflects recent market developments in France where authorities have ordered Alk's main competitor to temporarily suspend production.  Full Article

ALK Abello divests its European veterinary business
Monday, 21 Dec 2015 02:49am EST 

Alk Abello A/S:Alk divests its european veterinary business ‍.Agreement with buyer - Swedish Investment Company Fidelio Capital - is final and transaction will be effective as of Dec. 30, 2015.The value of the transaction is undisclosed, however, the divestment is expected to impact ALK’s full-year guidance on free cash flow positively by 40 million - 50 million Danish crowns.The divestment does not materially impact ALK’s full-year guidance for revenue and EBITDA before special items​.  Full Article

BRIEF-ALK-Abello names Carsten Hellmann new CEO

* Said on Tuesday Board of Directors had appointed Carsten Hellmann as new President and Chief Executive